Sabin Vaccine Institute Receives up to $6.3 Million from CEPI for Dose-Optimizing COVID-19 Vaccine Clinical Trial
May 17, 2022 15:48 ET | The Sabin Vaccine Institute
Washington, D.C., May 17, 2022 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute was awarded up to $6.3 million from the Coalition for Epidemic Preparedness Innovations (CEPI) for a clinical trial to...
Uniformity Labs Launches Ti-6Al-4V Grade 23 Titanium Alloy Powder for Laser Powder Bed Fusion (L-PBF)
May 17, 2022 09:00 ET | Uniformity Labs, Inc.
FREMONT, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Engineered materials company Uniformity Labs (Uniformity) announces the availability of titanium alloy Ti-6Al-4V (Ti64) powder for L-PBF. Developed...
VIPC’s Virginia Venture Partners Invests in Magazine Jukebox, Inc. to Provide Digital Alternative to Traditional Magazine Displays Richmond, VA, May 17, 2022 (GLOBE NEWSWIRE) -- Virginia Venture Partners, the equity investment program of Virginia Innovation Partnership Corporation (VIPC), today announced an investment in...
lumos.png
Lumos Pharma to Participate in Upcoming Investor Conferences
May 16, 2022 16:05 ET | Lumos Pharma, Inc.
AUSTIN, Texas, May 16, 2022 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the Company...
Cleartronic, Inc. Announces Financial Results for the Three Months Ended March 31, 2022
May 11, 2022 14:30 ET | Cleartronic, Inc.
BOCA RATON, Fla., May 11, 2022 (GLOBE NEWSWIRE) -- Cleartronic, Inc. (CLRI: OTCPINK) released its 2022 second fiscal quarter (Q2) financial statements for the three months ended March 31, 2022. CLRI...
MicrosoftTeams-image (5).png
Glycomics Market to Register Growth at CAGR of 11.2% During Forecast Period, TMR Study
May 11, 2022 10:30 ET | Transparency Market Research
Albany NY, United States, May 11, 2022 (GLOBE NEWSWIRE) -- Analysts at TMR estimate the glycomics market to reach US$ 3.1 Bn by 2031. Substantial research initiatives to study glycomics, which has...
Bio-Sig-Logo-horiz.jpg
BioSig Technologies, Inc. Issues Shareholder Letter with Corporate Update on Recent Achievements
May 11, 2022 08:30 ET | BioSig Technologies, Inc.
Westport, CT, May 11, 2022 (GLOBE NEWSWIRE) -- To date, Company's FDA 510(k) cleared PURE EP(TM) system has completed over 2,200 patient cases with 75 physicians at 17 hospitals across the...
Ki Young Sohn, CEO of Enzychem Lifesciences Honored by World Biz Magazine Leadership Awards With 'Top 100 Innovation CEO' Award
May 11, 2022 04:00 ET | World Biz Magazine
LONDON, May 11, 2022 (GLOBE NEWSWIRE) -- Ki Young Sohn is Chairman and CEO of Enzychem Lifesciences, a late-stage biotechnology company. With more than 30 years of experience in the life sciences...
OraSure Technologies, Inc. Logo
OraSure Reports 1Q22 Record Revenue of $67.7 Million; +16% Year-Over-Year With 21% Growth in Non-COVID Revenue
May 10, 2022 16:05 ET | OraSure Technologies, Inc.
InteliSwab® revenue of $22.1 million in Q1, up 50% sequentially with significant scaling in production Non-COVID molecular kits increase 42% year-over-year demonstrating continued strong growth ...
lumos.png
Lumos Pharma Reports First Quarter 2022 Financial Results and Clinical Development Updates
May 10, 2022 16:01 ET | Lumos Pharma, Inc.
--Phase 2 OraGrowtH210 Trial Reached 50% Randomization Milestone – Interim Data from Phase 2 and PK/PD OraGrowtH Trials Anticipated by End of 2022-- --FDA Permits Treatment with LUM-201 Beyond 12...